{"database": "openregs", "table": "documents", "rows": [["FDA-2022-P-0614-0005", "FDA", "FDA-2022-P-0614", "Interim Response Letter from FDA CDER to Yichang Humanwell Pharmaceuticals LLC", "Other", "Letter(s)", "2022-10-26T04:00:00Z", 2022, 10, "2022-10-26T04:00:00Z", null, "2022-10-26T12:25:39Z", null, 0, 0, "090000648545ccbf"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2022-P-0614-0005"], "units": {}, "query_ms": 5.191934993490577, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}